Jump to content

Bibrocathol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ozzie10aaaa (talk | contribs) at 15:26, 23 September 2023 (Cleaned up using AutoEd). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Bibrocathol
Clinical data
Other namesBibrocathin
Tetrabromopyrocatechol bismuth
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical (eye ointment)
ATC code
Identifiers
  • 4,5,6,7-tetrabromo-2-hydroxy-1,3,2-benzodioxabismole
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.027.294 Edit this at Wikidata
Chemical and physical data
FormulaC6HBiBr4O3
Molar mass649.667 g·mol−1
3D model (JSmol)
  • O[Bi]1Oc2c(Br)c(Br)c(Br)c(Br)c2O1
  • InChI=1S/C6H2Br4O2.Bi.H2O/c7-1-2(8)4(10)6(12)5(11)3(1)9;;/h11-12H;;1H2/q;+3;/p-3 checkY
  • Key:VTAVFIZOZUAKKE-UHFFFAOYSA-K checkY
 ☒NcheckY (what is this?)  (verify)

Bibrocathol (INN, trade names Noviform and Posiformin) is the substance 4,5,6,7-Tetrabrom-1,3,2-benzodioxabismol-2-ol. It contains bismuth and is used to treat eye infections and control swelling.[1]

References

  1. ^ Gurtler L (January 2002). "Chapter 2: The Eye and Conjunctiva as Target of Entry for Infectious Agents: Prevention by Protection and by Antiseptic Prophylaxis". In Kramer A, Behrens-Baumann W (eds.). Antiseptic prophylaxis and therapy in ocular infections: principles, clinical practice, and infection control. Developments in Ophthalmology. Vol. 33. Basel: Karger. pp. 9–13. doi:10.1159/000065934. ISBN 978-3-8055-7316-0. PMID 12236131.